Study suggests warfarin is acceptable for long-term treatment of cancer-associated thrombosis

Share :
Published: 5 Dec 2015
Views: 2536
Dr Chatree Chai-Adisaksopha - McMaster University, Hamilton, Canada

Dr Chai-Adisaksopha presents, at a press conference at ASH 2015, results from a study looking at switching patients to warfarin after 6-month completion of anticoagulant treatment for cancer-associated thrombosis.

Read the news story and watch the video interview for more information.